Mesoblast (MESO) Gains from Investment Securities (2015 - 2025)

Mesoblast has disclosed Gains from Investment Securities across 11 years of filings, most recently posting $503000.0 for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $503000.0, down 88.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $503000.0 (up 1722.58% YoY), and the FY2025 annual result was $4.3 million, up 1176.85% from the prior year.
• Gains from Investment Securities came in at $503000.0 for Q4 2025 at Mesoblast, down from $4.3 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $4.5 million in Q3 2022 to a low of -$18.1 million in Q1 2021.
• The 5-year median for Gains from Investment Securities is -$136000.0 (2022), against an average of -$1.9 million.
• Across the five-year window, Gains from Investment Securities sank 4566.67% in 2021 and jumped 1695.71% in 2022, its largest moves.
• Mesoblast's Gains from Investment Securities stood at -$528000.0 in 2021, then surged by 74.24% to -$136000.0 in 2022, then surged by 1052.94% to $1.3 million in 2023, then soared by 232.02% to $4.3 million in 2024, then tumbled by 88.31% to $503000.0 in 2025.
• The last three Gains from Investment Securities figures came in at $503000.0 (Q4 2025), $4.3 million (Q2 2025), and $4.3 million (Q4 2024), per Business Quant data.